Mental Health Awareness Month: Recognizing Pharmacogenetics as a Path for Treatment
A LinkedIn article describing Mental Health Awareness Month and Gulfstream Genomics' part of the collective effort in providing pharmacogenetics testing to those wanting to be prescribed the right drug the first time to improve mental health.
Gulfstream Diagnostic's Fleming Cited in the President's Commission on Combating Drug Addiction and the Opioid Crisis for the Synthetic Opioid U-47700
A LinkedIn article highlighting Mr. Steven Fleming's citation in the President's Commission on Combating Drug Addiction and the Opioid Crisis. Mr. Fleming is the Director of Toxicology and R&D at Gulfstream Diagnostics.
Getting on the Same Page: Standardization of Pharmacogenetic Terms
A LinkedIn article where I describe the Clinical Pharmacogenetics Implementation Consortium's (CPIC) update on standardizing pharmacogenetic terms to improve the understanding and interpretation of tests.